Platelet activating factor (PAF) is a relatively recently characterized, potent lipid which is now recognized as a pivotal mediator of acute inflammatory and allergic reactions. Of interest, a PAF-like mediator is present in normal human mixed saliva; however, the structural characterization of salivary PAF and its biological relevance in oral biology remain to be determined. Thus, the long-term objective of the proposed studies is to characterize human salivary PAF with respect to identification of its structure and elucidation of factors which modulate its concentration and biological activities in saliva. Specifically, these studies will: (1) identify factors which modulate the levels of salivary PAF; (2) determine the structures and biological activities of salivary PAF; (3) identify the source of salivary PAF; (4) characterize the PAF inhibitor(s) in normal human mixed saliva; and (5) evaluate the levels of both PAF and its inhibitor in mixed saliva obtained from individuals with varying degrees of periodontal disease. The data obtained will provide new and important information to facilitate a basic understanding of how this lipid may be involved in modulating normal as well as abnormal inflammatory processes in the oral cavity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
5R01DE008000-05
Application #
3221778
Study Section
Oral Biology and Medicine Subcommittee 1 (OBM)
Project Start
1987-06-01
Project End
1993-05-31
Budget Start
1991-06-01
Budget End
1993-05-31
Support Year
5
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
McManus, L M; Pinckard, R N (2000) PAF, a putative mediator of oral inflammation. Crit Rev Oral Biol Med 11:240-58
Woodard, D S; Mealey, B L; Lear, C S et al. (1995) Molecular heterogeneity of PAF in normal human mixed saliva: quantitative mass spectral analysis after direct derivatization of PAF with pentafluorobenzoic anhydride. Biochim Biophys Acta 1259:137-47
Woodard, D S; Ostrom, K K; McManus, L M (1995) Lipid inhibitors of platelet-activating factor (PAF) in normal human plasma. J Lipid Mediat Cell Signal 12:11-28
Garito, M L; Prihoda, T J; McManus, L M (1995) Salivary PAF levels correlate with the severity of periodontal inflammation. J Dent Res 74:1048-56
Rasch, M S; Mealey, B L; Prihoda, T J et al. (1995) The effect of initial periodontal therapy on salivary platelet-activating factor levels in chronic adult periodontitis. J Periodontol 66:613-23
McManus, L M; Ostrom, K K; Lear, C et al. (1993) Radiation-induced increased platelet-activating factor activity in mixed saliva. Lab Invest 68:118-24
McManus, L M; Marze, B T; Schiess, A V (1990) Deficiency of salivary PAF in edentulous individuals. J Periodontal Res 25:347-51